Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Tachycardia

2-amino-5-phosphonovalerate has been researched along with Tachycardia in 2 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Tachycardia: Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DiMicco, J1
Monroe, AJ1
Bhatnagar, T1
Chitravanshi, VC1
Sapru, HN1

Other Studies

2 other studies available for 2-amino-5-phosphonovalerate and Tachycardia

ArticleYear
Stimulation of metabotropic glutamate receptors in the dorsomedial hypothalamus elevates heart rate in rats.
    The American journal of physiology, 1996, Volume: 270, Issue:5 Pt 2

    Topics: 2-Amino-5-phosphonovalerate; Animals; Cycloleucine; Dose-Response Relationship, Drug; Glycine; Heart

1996
Cardiovascular responses to microinjections of excitatory amino acids into the area postrema of the rat.
    Brain research, 1999, Mar-20, Volume: 822, Issue:1-2

    Topics: 2-Amino-5-phosphonovalerate; Anesthetics, Intravenous; Animals; Blood Pressure; Bradycardia; Cerebra

1999